logo-loader
viewBlackberry

Roku, Blackberry, Rite Aid Corporation and more

A look at what's hot and what's not in pre-market deals in New York

1506600828_Blackberry-smartphone-881226_1280.jpg
Blackberry is something of a come-back story, as results showed

US shares in Wall Street are seen starting lower after a higher finish yesterday. Several stocks are in play, including a new float.

In focus will be Roku (NASDAQ:ROKU), the streaming TV and media firm, which makes its market debut today in New York on the Nasdaq index.

In doing so, it plans to sell shares worth US$219mln of shares, priced at US$14 each, valuing the group at US$1.3bn. Shares surged 30% when it debuted on Wall Street.

Meanwhile, Blackberry Ltd (NASDAQ:BBRY) shares added 7.48% to US$ 9.92 after hours as the Canadian smartphone giant announced second quarter numbers, which beat estimates.

The group for the three months reported revenue of US$249mln, which was higher than the US$221mln that had been expected. In the regular session, Blackberry shares added over 12% to US$10.38 each.

Rite Aid Corporation (NYSE:RAD) shares  lost 2.63% to US$2.22 as it is projected to report quarterly earnings at $0.01 per share on revenues of $7.84bn. Shares dropped 11.18% in the regular session to US$2.02.

Accenture Plc (NYSE:ACN) shares lost 1.57% to US$134.50. The group is expected to report quarterly earnings at $1.46 per share on revenue of $8.99bn. Shares on Thursday eased 0.20$ to US$136.36.

Quick facts: Blackberry

Price: 7.38 CAD

TSX:BB
Market: TSX
Market Cap: $4.09 billion
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Tonix Pharmaceuticals CEO talks through recent pre-clinical and clinical...

Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) CEO Seth Lederman sat down with Proactive at the BIO CEO & investor Conference in New York. Lederman says the biopharma company had recently unveiled the pre-clinical results of TNX-801, its live virus horsepox vaccine that prevents...

4 hours, 5 minutes ago

2 min read